lazabemide (Tempium, Ro-19-6327)
Jump to navigation
Jump to search
Indications
- treatment of Parkinson's disease
Mechanism of action
- MAO inhibitor, inhibits MAO type-B
More general terms
- monoamine oxidase [MAO] inhibitor
- aromatic compound
- amine
- pharmacologic agents for treatment of Parkinson's disease
References
- ↑ Medical Knowledge Self Assessment Program (MKSAP) 16 American College of Physicians, Philadelphia 2012